These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38744732)

  • 1. Development of Amorphous Solid Dispersion Sustained-Release Formulations with Polymer Composite Matrix-Regulated Stable Release Plateaus.
    Chen L; Hu E; Shen P; Qian S; Heng W; Zhang J; Gao Y; Wei Y
    Pharm Res; 2024 Jun; 41(6):1233-1245. PubMed ID: 38744732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PVP VA64 as a novel release-modifier for sustained-release mini-matrices prepared via hot melt extrusion.
    Li Y; Lu M; Wu C
    Drug Deliv Transl Res; 2018 Dec; 8(6):1670-1678. PubMed ID: 29127610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How changes in molecular weight and PDI of a polymer in amorphous solid dispersions impact dissolution performance.
    Auch C; Harms M; Mäder K
    Int J Pharm; 2019 Feb; 556():372-382. PubMed ID: 30553957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
    Danda LJA; Batista LM; Melo VCS; Soares Sobrinho JL; Soares MFR
    Eur J Pharm Sci; 2019 May; 133():79-85. PubMed ID: 30890364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
    Agrawal AM; Dudhedia MS; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
    Dedroog S; Huygens C; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
    Xi L; Song H; Wang Y; Gao H; Fu Q
    AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a ternary amorphous solid dispersion using hot-melt extrusion for obtaining a stable colloidal dispersion of amorphous probucol nanoparticles.
    Hanada N; Higashi K; Zhao Z; Ueda K; Moribe K
    Int J Pharm; 2023 Jun; 640():122959. PubMed ID: 37086931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Solid Dispersion by Hot Melt Extrusion Using Mixtures of Polyoxylglycerides With Polymers as Carriers for Increasing Dissolution Rate of a Poorly Soluble Drug Model.
    Vasoya JM; Desai HH; Gumaste SG; Tillotson J; Kelemen D; Dalrymple DM; Serajuddin ATM
    J Pharm Sci; 2019 Feb; 108(2):888-896. PubMed ID: 30257196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
    Faiz Afzal MA; Lehmkemper K; Sobich E; Hughes TF; Giesen DJ; Zhang T; Krauter CM; Winget P; Degenhardt M; Kyeremateng SO; Browning AR; Shelley JC
    Mol Pharm; 2021 Nov; 18(11):3999-4014. PubMed ID: 34570503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.
    Bordos E; Islam MT; Florence AJ; Halbert GW; Robertson J
    Mol Pharm; 2019 Oct; 16(10):4361-4371. PubMed ID: 31436094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.